BioNTech

Bristol Myers Squibb has two sites in Lawrenceville. -BRISTOL MYERS SQUIBB
Jun 3, 2025

Bristol Myers Squibb, BioNTech partner on $11B cancer drug deal

The companies will co-develop and co-commercialize the Germany-based biopharmaceutical's next-generation immunotherapy BNT327 across numerous solid tumor types.